Gene · 407014
Papers3,611
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
701 to 720 of 3,611
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Signaling cascades in the failing heart and emerging therapeutic strategies. | Signal Transduct Target Ther | 2022 | 35461308 | PubTator, text mining | PubMed |
| MicroRNA as Candidate Biomarkers in Atypical Parkinsonian Syndromes: Systematic Literature Review. | Medicina (Kaunas) | 2022 | 35454322 | PubTator, text mining | PubMed |
| Patient-Derived Tumor Organoids: New Progress and Opportunities to Facilitate Precision Cancer Immunotherapy. | Front Oncol | 2022 | 35449581 | PubTator, text mining | PubMed |
| Two-Dimensional Quantum Dot-Based Electrochemical Biosensors. | Biosensors (Basel) | 2022 | 35448314 | PubTator, text mining | PubMed |
| Role of MicroRNAs in Neuroendocrine Prostate Cancer. | Noncoding RNA | 2022 | 35447888 | PubTator, text mining | PubMed |
| Identification and Contribution of Inflammation-Induced Novel MicroRNA in the Pathogenesis of Systemic Lupus Erythematosus. | Front Immunol | 2022 | 35444657 | PubTator, text mining | PubMed |
| Contribution of MicroRNAs in Chemoresistance to Cisplatin in the Top Five Deadliest Cancer: An Updated Review. | Front Pharmacol | 2022 | 35444536 | PubTator, text mining | PubMed |
| Ruscogenin Attenuates Lipopolysaccharide-Induced Septic Vascular Endothelial Dysfunction by Modulating the miR-146a-5p/NRP2/SSH1 Axis. | Drug Des Devel Ther | 2022 | 35440867 | PubTator, text mining | PubMed |
| Integrative Analyses of Circulating mRNA and lncRNA Expression Profile in Plasma of Lung Cancer Patients. | Front Oncol | 2022 | 35433477 | PubTator, text mining | PubMed |
| Targeting non-coding RNAs to overcome cancer therapy resistance. | Signal Transduct Target Ther | 2022 | 35418578 | PubTator, text mining | PubMed |
| Omics-based biomarkers for diagnosis and prediction of kidney allograft rejection. | Korean J Intern Med | 2022 | 35417937 | PubTator, text mining | PubMed |
| RBM24 in the Post-Transcriptional Regulation of Cancer Progression: Anti-Tumor or Pro-Tumor Activity? | Cancers (Basel) | 2022 | 35406615 | PubTator, text mining | PubMed |
| MicroRNA-Mediated Epigenetic Regulation of Rheumatoid Arthritis Susceptibility and Pathogenesis. | Front Immunol | 2022 | 35401568 | PubTator, text mining | PubMed |
| mRNA-miRNA bipartite networks reconstruction in different tissues of bladder cancer based on gene co-expression network analysis. | Sci Rep | 2022 | 35393513 | PubTator, text mining | PubMed |
| MicroRNA-23a-3p targeting of HMGB1 inhibits LPS-induced inflammation in murine macrophages in vitro. | Exp Ther Med | 2022 | 35386623 | PubTator, text mining | PubMed |
| Systematic review of preterm birth multi-omic biomarker studies. | Expert Rev Mol Med | 2022 | 35379367 | PubTator, text mining | PubMed |
| Overcome Drug Resistance in Cholangiocarcinoma: New Insight Into Mechanisms and Refining the Preclinical Experiment Models. | Front Oncol | 2022 | 35372014 | PubTator, text mining | PubMed |
| The Interplay Between Gut Microbiota and miRNAs in Cardiovascular Diseases. | Front Cardiovasc Med | 2022 | 35369298 | PubTator, text mining | PubMed |
| Vitiligo-specific soluble biomarkers as early indicators of response to immune checkpoint inhibitors in metastatic melanoma patients. | Sci Rep | 2022 | 35361879 | PubTator, text mining | PubMed |
| The Role of Tumor Stem Cell Exosomes in Cancer Invasion and Metastasis. | Front Oncol | 2022 | 35350566 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/407014/papers?page=36